Brean Capital Raises Price Target as Cynosure (CYNO) Delivers Strong 2Q Results
Brean Capital reiterated a Buy rating on Cynosure (NASDAQ: CYNO), and raised the price target to $60.00 (from $54.00), following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
